Kyrgyzstan Medical Device Registration Application Form and Power of Attorney: Requirements and Best Practices
Updated: 2026-11-12 · GRZAN Regulatory Team · Verification date 2026-10-20
1. Key takeaways
The application package for medical device registration in Kyrgyzstan consists of three building blocks: the application form in the prescribed format (Annex 1 of the official forms published by the competent authority), the notarized and legalized power of attorney from the manufacturer, and the applicant’s declaration of responsibility for the accuracy of the information and documents submitted (Annex 10). The logic is clear: the application form defines what is being applied for, the power of attorney defines who is entitled to apply, and the declaration defines who bears the consequences if the information proves false. The third block is the one most often treated as a formality, yet it is legally linked to the grounds for revocation of the registration certificate. Getting all three right at the outset prevents the most common acceptance-stage delays.
2. Legal basis
- Official form Annex 1 published by the competent authority: the format of the medical device registration application form.
- Official form Annex 10: the applicant’s declaration of responsibility for the accuracy of the information and documents submitted.
- Official form Annex 2: the dossier amendment application form; Annex 3: the withdrawal application form; Annex 4: the registration certificate format.
- Resolution No. 513 of the Cabinet of Ministers, dated August 27, 2024, Annex 1, Article 2: the authorized representative of the manufacturer acts on the basis of the manufacturer’s power of attorney, representing its interests and bearing responsibility; the applicant is the person who submits the registration application.
- Law No. 216, Article 15: providing false information constitutes a ground for revocation of the registration certificate.
3. Expert insights
Insight 1: The power of attorney is not a single sheet of paper but a chain of authorization.
The legal effect of a power of attorney depends on four elements: the signing authority of the grantor (the manufacturer); the identity and residence status of the grantee (the authorized representative); the scope of authorization; and the term of authorization. If any one of the four is missing or defective, the power of attorney can be questioned at the acceptance stage. We recommend bundling the power of attorney with the authorized representative’s corporate status documents (registration certificate, tax certificate, proof of residence status) into a single qualification package and submitting it together with the application. Preparing the package once and reusing it across multiple product registrations saves significant time on multi-product programs.
Insight 2: The scope of authorization should be listed item by item, not granted in general terms.
We recommend that the scope cover at least seven items: submitting the registration application; signing application documents and declarations; receiving official correspondence; processing amendments to the registration dossier; processing suspension and revocation of the certificate; handling import procedures; and performing post-market surveillance and vigilance obligations. A scope that is too narrow stalls the process (for example, if the representative cannot formally receive a deficiency notice), while a scope that is too broadly worded is difficult to control internally. An itemized list lets the accepting authority confirm authority at a glance and lets the manufacturer enforce boundaries internally.
Insight 3: The Annex 10 declaration and Article 15 of Law No. 216 form a closed loop.
The competent authority requires the applicant to sign the declaration of responsibility for the accuracy of the submitted information and documents. Article 15 of Law No. 216 lists providing false information as a ground for revocation of the registration certificate. Together, the two provisions mean that the validity of the certificate rests on the continuing truthfulness of the information provided at the time of application. If, after the certificate is issued, it emerges that a prerequisite (such as confirmation of circulation in the country of manufacture or a positive expert assessment) was inaccurate, the consequence is revocation rather than correction. Treat the declaration as a substantive legal commitment, not paperwork.
Insight 4: Consistency among the three blocks is the first check at acceptance.
The manufacturer name and address, and the model designations and specifications, stated in the application form must match the grantor information in the power of attorney and the entries on the free sale certificate word for word. A single inconsistency (for example, a different abbreviation of the manufacturer’s English name, or a different way of writing the building number in the address) is enough to trigger a deficiency letter. We recommend a two-column comparison table that places the key fields of the three documents side by side and verifies each cell individually before filing.
Insight 5: The term of authorization should match the product life cycle, with a renewal window reserved.
The registration certificate is valid indefinitely (Article 15), but the appointment of an authorized representative is time-limited. If the power of attorney expires before the end of the product’s life cycle, the representative must be replaced and the change processed, which touches both the registration dossier and the account in the electronic system. We recommend setting the initial term of the power of attorney long enough to cover the expected life cycle and agreeing in the underlying contract on automatic renewal with advance notice obligations.
4. Practical recommendations
First, standardize the qualification package. We recommend it contains: the manufacturer’s registration documents; the authorized representative’s registration and residence status documents; the notarized and legalized power of attorney; and evidence of the signing officer’s authority. Build it once and reuse it across product lines, refreshing only the items that have expired.
Second, draft the scope of authorization as an itemized list of the seven functions. Use enumerative wording rather than general wording. This accelerates confirmation by the accepting authority and gives the manufacturer a clear internal benchmark for what the representative may and may not do.
Third, verify key fields cell by cell in a comparison table. We recommend a table with the fields down the left side (manufacturer name, address, models, specifications, production sites) and the documents across the top (application form, power of attorney, free sale certificate, quality system certificate, labeling). Tick each cell only after a literal comparison.
Fourth, set the power of attorney term by the product life cycle. The initial term should cover the expected life cycle, with automatic renewal and advance notice obligations written into the representation agreement, so that representation never lapses mid-cycle.
5. Verification checklist
- □ The current published Annex 1 application form is used, not an outdated version;
- □ The power of attorney has completed notarization and legalization and has been translated into Russian (the sequence original document, notarization, legalization, translation is correct);
- □ The scope of authorization in the power of attorney lists the seven functions item by item;
- □ The term of authorization matches the product life cycle, with automatic renewal agreed in the contract;
- □ The Annex 10 declaration has been signed by a person with signing authority, whose authority is consistent with the scope in the power of attorney;
- □ Cell-by-cell verification completed in the key-field comparison table (application form, power of attorney, free sale certificate, quality system certificate, labeling).
Regulatory information verified as of October 29, 2026.
Our services cover: pre-market pathway selection and feasibility assessment, registration dossier preparation and submission, authorized representative arrangements, local testing and clinical trial organization, manufacturing site inspection coordination, quality management system compliance support, post-market surveillance and device vigilance system setup, import and distribution compliance, and fee calculation and project budget management.
The GRZAN regulatory team consists of professionals with many years of hands-on experience in Eurasian Economic Union registration. We maintain a stable local cooperation network in Bishkek, Almaty, Tashkent and Moscow, work in Chinese, Russian and English, and provide executable solutions for foreign manufacturers on the issues most commonly encountered in CIS markets: authorized representative arrangements, notarization and legalization chains for powers of attorney, technical documentation localization, and inspection readiness. GRZAN supports manufacturers, importers and authorized representatives throughout the Kyrgyzstan registration lifecycle.
We adhere to one principle: every regulatory conclusion we publish must rest on verifiable official sources. Any figure or timeframe that cannot be verified is labeled as a practical estimate and is never presented as a legal requirement.
For project consultation on market access in Kyrgyzstan or the Eurasian Economic Union, please contact us at info@grzanglobal.com.
GRZAN | Global Medical Device Regulatory Registration and Compliance Services
Disclaimer
Prepared by GRZAN from publicly available regulation. It is provided for general information only and does not constitute legal advice. Legislation and official fees are subject to change by the competent authority.
About GRZAN
GRZAN (Global Regulatory Zone Access Navigator) — the global market-access navigator for medical devices and IVDs.
GRZAN is a specialist consultancy for medical device and IVD market access, providing end-to-end regulatory solutions across the product lifecycle and making international market entry simpler and faster.
Key figures. More than 25 wholly owned subsidiaries worldwide covering 50+ countries and regions; chosen by 100+ listed and leading Chinese device manufacturers, with 4,000+ successful cases; 12+ years in the sector and 200+ regulatory training sessions and seminars delivered.
What we do. Global market access: multi-country registration programmes, technical documentation, regulatory advice. Clinical evidence: clinical evaluation reports (CER), usability studies, overseas clinical investigations. Quality systems: ISO 13485, MDSAP, FDA QMSR and BGMP implementation and audit readiness. Authorised representative and licence-holder services across Southeast Asia, Latin America, the Middle East, Africa, Europe and North America.
Why GRZAN. A real operating entity, with the certificate held by the manufacturer: our direct overseas subsidiaries act as the compliant local holder, so the regulatory relationship stays clear and you keep control rather than being tied to a distributor. Direct access to the team: no time-zone gap, no language barrier, no cultural gap. Review points anticipated: we know what FDA 510(k), EU MDR, Southeast Asian, Latin American and Middle Eastern reviewers look for, which shortens timelines and reduces deficiency letters. Pathway planning: pre-decision analysis and risk assessment before you commit.
Every engagement rests on three commitments: efficiency through pre-submission review, certainty through a clear pathway, and stability through a licence-holder that stays in place.
Take your devices global with GRZAN
We work with manufacturers worldwide to open new markets with a clear regulatory pathway.
Contact us